{"schema_version":"1","generated_at":"2026-10-28T17:29:03.033Z","data_as_of":null,"url":"https://www.findmykol.com/kol/reuven-schore","json_url":"https://www.findmykol.com/kol/reuven-schore/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"reuven-schore","name":"Reuven Schore","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Washington","state":"DC","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1033204227","orcid":"0000-0002-1582-2168","openalex":"A5013922885"},"summary":"Reuven Schore is an Oncology physician. OpenAlex indexes 76 publications with 1,346 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":76,"cited_by_count":1346,"h_index":15,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02484261","title":"Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Reuven Schore","source_url":"https://clinicaltrials.gov/study/NCT02484261","trial_url":"https://www.findmykol.com/trial/NCT02484261"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2021,"amount_usd":3840,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033204227"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1033204227","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2014,"last":2017},"rows_total":4,"shown":3,"withheld":1,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"U01CA183030","title":"Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML","fiscal_year":2017,"amount_usd":"521464","organization":"CHILDREN'S RESEARCH INSTITUTE","source_url":"https://reporter.nih.gov/quickSearch/U01CA183030"},{"project":"U01CA183030","title":"Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML","fiscal_year":2016,"amount_usd":"472123","organization":"CHILDREN'S RESEARCH INSTITUTE","source_url":"https://reporter.nih.gov/quickSearch/U01CA183030"},{"project":"U01CA183030","title":"Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML","fiscal_year":2015,"amount_usd":"628352","organization":"CHILDREN'S RESEARCH INSTITUTE","source_url":"https://reporter.nih.gov/quickSearch/U01CA183030"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia","year":2025,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-025-02633-3","status":"verified"},{"title":"Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025017837","status":"verified"},{"title":"Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial","year":2025,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.31584","status":"verified"},{"title":"Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report","year":2024,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-024-02166-1","status":"verified"},{"title":"Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia","year":2024,"journal":"Research Square","source_url":"https://doi.org/10.21203/rs.3.rs-5292018/v1","status":"verified"}],"source":"works"},"contact":{"address_1":"111 MICHIGAN AVE NW","city":"Washington","state":"DC","zip":"200102978","phone":"202-884-2976","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1033204227","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}